• Ann Tucker

AMA Releases Issue Briefs on Worsening Epidemic, State-Level Reports to Increase Access to Evidence-

Drug overdose epidemic worsened during the COVID pandemic

The nation’s COVID pandemic made the nation’s drug overdose epidemic worse. This issue brief highlights media and other reports showing increases in drug overdose mortality and other concerns relating to access to evidence-based care for substance use disorders, patients with pain as well as harm reduction services. The reports below cite data from multiple and varied sources, including national, state and local public health agencies, law enforcement, emergency medical services, hospitals, treatment centers, research journals and others. Every state has reported a spike or increase in overdose deaths or other problems during the COVID pandemic.

Read more


Reports of efforts to help the nation's overdose epidemic

Despite the continuing COVID-19 global pandemic and the nation’s worsening drug overdose epidemic, the American Medical Association also has seen efforts in many states to increase access to evidencebased treatment. The AMA remains greatly concerned by a continuing number of reports from national, state and local media suggesting increases in opioid- and other drug-related mortality—particularly from illicitly manufactured fentanyl, fentanyl analogs, methamphetamine and cocaine. The AMA also continues to highlight the latest research and data to help provide evidence-based data and other information to help policymakers undertake meaningful public health interventions.

Read more

1 view0 comments

Recent Posts

See All

SAMHSA (11/10) –– The Substance Abuse and Mental Health Services Administration is pleased to announce the release of the agency’s Interim Strategic Plan (ISP), which presents a new mission and vision

The White House budget office is reviewing a draft SAMHSA rule that would make permanent the COVID-19 methadone take-home waiver and define which patients with OUD are considered “stable” enough to re